Enzymatic preparation of κ-carrageenan oligosaccharides and their anti-angiogenic activity

This publication has 32 references indexed in Scilit:

• Antiangiogenesis therapy in the treatment of metastatic colorectal cancer
  Therapeutic Advances in Medical Oncology, 2012
• FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
  Nature Reviews Cancer, 2008
• The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo
  PLOS ONE, 2008
• Preparation of a low-molecular weight fraction by free radical depolymerization of the sulfated galactan from Schizymenia binderi (Gigartinales, Rhodophyta) and its anticoagulant activity
  Carbohydrate Polymers, 2006
• Angiogenesis in life, disease and medicine
  Nature, 2005
• Antiviral Activity of a Carrageenan fromGigartina skottsbergiiagainst Intraperitoneal MurineHerpes simplexVirus Infection
  Planta Medica, 2005
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
  Science, 2005
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Preparation of O-acylated low-molecular-weight carrageenans with potent anti-HIV activity and low anticoagulant effect
  Carbohydrate Polymers, 2000
• What Is the Evidence That Tumors Are Angiogenesis Dependent?
  JNCI: Journal of the National Cancer Institute, 1990